![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1699.jpg)
So what have the trials shown us?
All 5 Oxaliplatain trials used low dose
oxaliplatin as a radiosensitizer with CRT
2 trials mandated oxaliplatin also as
postoperative adjuvant (so if benefit which
component?)
Some of the 5 trials did not mandate TME